Identification of the agent of Southern Tick Associated Rash Illness
Identification of the agent of Southern Tick Associated Rash Illness
批准号:
10364660
负责人:
Rafal Tokarz
金额:
$20.25万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
已结题
起止时间:
2021-03-08 至 2023-08-31
关键词:
AcuteAmblyommaAmbylomma americanumAntibiotic TherapyAntibodiesAreaBiopsyBiteBlack-legged TickCatalogsCenters for Disease Control and Prevention (U.S.)ClinicalCollaborationsDevelopmentDiagnosisDiagnostic testsDiseaseEnzyme-Linked Immunosorbent AssayEpidemiologyEtiologyExanthemaExposure toFeverLyme DiseaseMetagenomicsMicrobeMolecularPatientsPeptidesPhasePhysiciansPublic HealthReportingSamplingSerologySerology testSigns and SymptomsSiteSkinSouthern Tick Associated Rash IllnessSymptomsSyndromeTestingTick-Borne DiseasesTicksTreatment ProtocolsUnited StatesUnited States National Institutes of HealthWorkaccurate diagnosticsbaseclinical diagnosisdesigndiagnostic toolerythema migransimmunoreactivitymetagenomic sequencingmicrobialpathogenskin lesiontick bitetoolvector
中文摘要
点击翻译按钮获取中文摘要
英文摘要
ABSTRACT
Southern Tick Associated Rash Illness (STARI) is febrile illness that occurs following bites of Amblyomma
americanum ticks. Although it was initially reported over two decades ago, the agent of STARI remains
unknown, and no diagnostic tests are available. The recent northward expansion of A. americanum has
brought these ticks into areas highly endemic for Lyme disease. The primary indicator of STARI is an
expanding rash around the tick bite, that can be misdiagnosed as an erythema migrans. The similarity of the
rash and the accompanying non-specific symptoms presents challenges for physicians. In addition, there is a
lack of defined treatment protocols for STARI. While it has been suggested that antibiotic treatment may have
utility, this has not been clearly demonstrated. The identification of the STARI agent would have profound
effects on the ability to diagnose and treat this syndrome, as well as clarify the epidemiology of this illness. In
this proposal, we will employ state of the art molecular and serologic tools to identify the agent of STARI. We
will identify unique microbial sequences through comprehensive metagenomic sequencing of skin biopsies
taken from within the STARI rash and attached ticks. We will then develop serologic assays to demonstrate
exposure to this agent in sera from STARI patients. This work will determine the microbial origin of STARI and
enhance opportunities for accurate diagnostics and therapy.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Genetic basis for persistence of Borrelia burgdorferi
-
批准号:10737678
-
项目类别:
-
资助金额:$55.98万
-
财政年份:2023
-
负责人:Rafal Tokarz
-
依托单位:
海外基金